pharmaceuticals
Dr. Reddy’s Laboratories Limited Q2FY23; Net Profit Increased By 12%
Dr. Reddy's Laboratories Limited (NSE: DRREDDY) reported Revenue from Operations for Q2 FY23 of ₹63,318 Crore up from ₹57,896 Crore…
Dr. Reddy’s Laboratories (DRREDDY) Q2 FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE: DRREDDY) Q2 FY23 Earnings Concall dated Oct. 28, 2022 Corporate Participants: Amit Agarwal -- Head of…
Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23
Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR…
Jubilant Pharmova Limited (JUBLPHARMA) Q2 FY23 Earnings Concall Transcript
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Surajit Pal -- Head, Investor Relations…
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Sudhir Menon -- Chief Financial Officer…
Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head -…